An article has been published in the PharmacoEconomics (A', A'') journal, where the first author is Associate Professor Dr Valentina Prevolnik Rupel, a higher education teacher at DOBA Business School.
“The EQ-5D-Y value set for Slovenia has been published in PharmacoEconomics journal: EQ-5D-Y value set, Slovenia. This is the first EQ-5D-Y value set published for any country around the world. EQ-5D-Y is a child and youth-friendly version of the widely used EQ-5D-3L instrument, which was developed by the EuroQol Group in 2009 to allow child and adolescent respondents to directly self-report their health, without having to rely on reports from intermediaries (e.g. through adult proxies). Until now, no value sets have been available for EQ-5D-Y and research has shown that EQ-5D-3L or EQ-5D-5L value sets (used for adult populations) should not be used to assign values to EQ-5D-Y health states. Consequently, the calculation of quality-adjusted life-years (QALYs) using the EQ-5D-Y instrument has not been possible. The publication of the first EQ-5D-Y value set marks the beginning of a new era where the EQ-5D-Y instrument, in combination with EQ-5D-Y value sets, can be used in cost-utility analysis to inform evaluations of healthcare interventions for use in child and adolescent populations. The value set for Slovenia was derived using the international EQ-5D-Y valuation protocol and is the first in a series of EQ-5D-Y valuation studies, that are due to be completed and published over the coming months.”